Theralase Technologies Inc.
TLTFF
$0.17
$0.014.06%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.63% | 25.02% | -6.88% | 16.95% | -9.11% |
| Total Depreciation and Amortization | -6.17% | 6.53% | -3.99% | -9.37% | -10.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -38.44% | -63.50% | 41.51% | 76.07% | 16.31% |
| Change in Net Operating Assets | -26.53% | -428.91% | 113.98% | -149.24% | 1,860.23% |
| Cash from Operations | 28.48% | -156.08% | 50.38% | -149.43% | 69.65% |
| Capital Expenditure | 98.67% | 716.33% | -74.60% | -1,250.00% | -1,566.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 101.78% | 716.33% | -74.60% | -1,250.00% | -1,566.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.05% | 48.12% | -24.68% | -27.39% | -7.52% |
| Issuance of Common Stock | 258.14% | 126.09% | -48.78% | 31.54% | -74.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | 291.91% | 202.39% | -43.04% | 30.26% | -77.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 718.22% | 268.43% | 134.76% | -126.94% | -282.60% |